COMMUNIQUÉS West-GlobeNewswire

Half-Year Report on the DBV Technologies Liquidity Contract with Natixis

05/07/2017 - 22:30

AMF REGULATED INFORMATION Montrouge, France, July 5, 2017 Half-Year Report on the DBV Technologies Liquidity Contract with Natixis Under the liquidity contract between DBV TECHNOLOGIES and NATIXIS, the following assets [...]

Minerva Neurosciences Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares

05/07/2017 - 22:05

WALTHAM, Mass., July 05, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company, today announced the closing of its previously announced public offering of 5,750, [...]

Prothena Announces Initiation of Phase 2 PASADENA Study of PRX002/RG7935 in Patients with Early Parkinson's Disease

05/07/2017 - 22:05

First potentially disease-modifying anti-alpha-synuclein antibody to be evaluated for efficacy in patients with Parkinson's disease Prothena to receive $30 million milestone payment under collaboration agreement with [...]

Arques Clinic : FAB Generation: Fabulous at Fifty and Beyond

05/07/2017 - 19:13

MARBELLA, SPAIN--(Marketwired - Jul 5, 2017) - Being 50 years old has really changed in the last 20 years and now doesn't feel that old. The classic stereotype is being replaced by a new standard: the Fabulous at Fifty [...]

Nature Publication Reports Favorable Clinical Trial Results of BioNTech's Individualized Cancer Vaccine IVAC® MUTANOME

05/07/2017 - 19:04

- First-ever clinical study demonstrates personalized RNA-based vaccine using mutant neo-epitopes as antigens activates immune system against individual mutations and exerts anti-cancer activity - MAINZ, Germany, July [...]

Essilor : Nombre total de droits de vote et d'actions composant le capital social au 30 juin 2017

05/07/2017 - 18:00

Nombre total de droits de vote et d'actions composant le capital social au 30 juin 2017 (Article L.233-8 II du Code de Commerce et les articles 221-1 et 223-16 du Règlement Général de l'AMF) Charenton-le-Pont, France ( [...]

Essilor: Disclosure of Share Capital and Voting Rights Outstanding as of June 30, 2017

05/07/2017 - 18:00

Disclosure of Share Capital and Voting Rights Outstanding as of June 30, 2017 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des [...]

Deinove : le processus d'industrialisation du programme caroténoïdes entre en phase II

05/07/2017 - 18:00

DEINOVE : LE PROCESSUS D'INDUSTRIALISATION DU PROGRAMME CAROTÉNOÏDES ENTRE EN PHASE II La Phase I du programme a permis de sélectionner la première molécule caroténoïde qui sera produite à échelle industrielle courant [...]

Deinove: the industrialization process of the carotenoids program enters phase II

05/07/2017 - 18:00

DEINOVE: THE INDUSTRIALIZATION PROCESS OF THE CAROTENOIDS PROGRAM ENTERS PHASE II Phase I of the program selected the first carotenoid molecule to be produced on an industrial scale in 2018. The yields obtained in 20- [...]

Solon Eiendom ASA - Primary insider notification

05/07/2017 - 17:39

SOLON EIENDOM ASA STOCK EXCHANGE ANNOUNCEMENT Solon Eiendom ASA - Primary insider notification (Oslo, Norway, 5 July 2017) Solon Eiendom ASA Board Member Tore Aksel Voldberg (through his wholly owned company Skøien AS) [...]

ProMIS Neurosciences to Present Preclinical Data from Alzheimer's Disease Program at AAIC 2017

05/07/2017 - 15:01

Chief Development Officer Dr. Johanne Kaplan to chair session ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE (AAIC): 16-20 JULY, 2017 LONDON, ENGLAND TORONTO, Ontario and CAMBRIDGE, Massachusetts - July 5, 2017 - [...]

Medibio Appoints Mental Healthcare Advocate and Former Congressman, Patrick Kennedy, to Board of Directors

05/07/2017 - 15:00

SYDNEY, Australia and MINNEAPOLIS, July 05, 2017 (GLOBE NEWSWIRE) -- Australian Stock Exchange listed medical technology company Medibio Limited (MEB or the Company) is pleased to announce the appointment of The [...]

Auris Medical Completes Enrollment of Phase 3 HEALOS Trial of AM-111 for the Treatment of Sudden Deafness

05/07/2017 - 14:00

Top-line results from the HEALOS trial are expected in the fall of 2017 Zug, Switzerland, July 5, 2017 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that [...]

ProQR's Drug Candidate QRX-411 for Usher Syndrome Receives Orphan Drug Designation from FDA and EMA

05/07/2017 - 13:00

Key Updates ProQR's QRX-411 receives Orphan Drug Designation by the FDA and EMA for the treatment of retinitis pigmentosa, including Usher syndrome, the subtype targeted by QRX-411. Usher syndrome is an inherited [...]

Publishing of Orion Corporation's Half-Yearly Report for January-June 2017 on 19 July 2017

05/07/2017 - 11:15

ORION CORPORATION PRESS RELEASE 5 JULY 2017 at 12.15 EEST Publishing of Orion Corporation's Half-Yearly Report for January-June 2017 on 19 July 2017 Orion will publish its Half-Yearly Report for January-June 2017 on [...]

MPI raised SEK 10,3 million in rights issue

05/07/2017 - 11:01

Hoersholm, Denmark, July 5 th, 2017 - Medical Prognosis Institute A/S ("MPI") today announced that approximately SEK 10,3 million before issue costs has been raised. This amount secures financing until H2 2018. A total [...]

Acarix Receives First German Commercial Order For CADScor®System For Early Detection Of Coronary Artery Disease From Private Cardiology Clinic In Berlin

05/07/2017 - 08:00

Malmö, July 5, 2017 Acarix Receives First German Commercial Order For CADScor ® System For Early Detection Of Coronary Artery Disease From Private Cardiology Clinic In Berlin Commercialization program on track as [...]

IBA SA : IBA signe un contrat pour l'installation d'un centre de protonthérapie en Virginie, États-Unis

05/07/2017 - 07:35

IBA signe un contrat pour l'installation d'un centre de protonthérapie en Virginie, États-Unis Contrat signé avec Inova Health Care Services pour l'installation d'une solution Proteus ® PLUS avec deux salles de [...]

IBA SA : IBA to Install Proton Therapy Center in Virginia, USA

05/07/2017 - 07:35

IBA to Install Proton Therapy Center in Virginia, USA Contract signed with Inova Health Care Services for two-room Proteus ® PLUS* proton therapy system near IBA's North American Headquarters Reston, VA, USA, July 5 th [...]